Delivery Order SPE2DB25D3202-SPE2DB25FTBAE
- Not listed
- The Defense Logistics Agency awarded a $24,495 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop product (3ML units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier to...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.13 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ml) on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed price delivery order with no set-aside designation, to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitively awarded transaction under AmerisourceBergen's existing federal contract portfolio...
- The Defense Logistics Agency awarded a delivery order valued at $8,490.73 to AmerisourceBergen Drug Corp on September 4, 2025, for MIEBO 100% eye drop solution in 3ml quantities. The contract is a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 5, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $9,567.86 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Miebo 100% eye drop medication in 3 milliliter units. This is a firm fixed price contract with no set-aside designation, reflecting open competition based on AmerisourceBergen's demonstrated capability to meet federal procurement requirements. The contract is set for ultimate completion on September 11, 2025, and will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,830.29 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop 3ML on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the company's place of performance in Conshohocken, PA. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,636.68 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for MIEBO 100% eye drop (3ml), with performance completed by July 28, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $3,817.41 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $30,256.76 for MIEBO 100% eye drop supply (3ml units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,723.79 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBAEDelivery Order
The Defense Logistics Agency awarded a $8,694.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of MIEBO 100% Eye Drop in 3ML units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for ultimate completion on July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. Through its extensive federal contract portfolio with the Defense Logistics Agency and Defense Health Agency, AmerisourceBergen has demonstrated capability to fulfill diverse medical procurement requirements across multiple therapeutic domains at varying transaction values, positioning it as a critical vendor for federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 7/28/25 |